Keck School Faculty

Michael P Dube, MD
Michael P Dube, MD
Professor of Medicine (Clinical Scholar);Associate Medical Director of the Rand Schrader AIDs Clinic;Interim Chief, Infectious Disease
Medicine
GNH 5P2 349 Health Sciences Campus Los Angeles
Dr. Dubé is an attending physician at the Los Angeles County-USC Medical Center in Los Angeles. He is the Associate Director of the 5P21 Rand Schrader Health and Research Center at LA County-USC Medical Center. Dr. Dubé is also a Professor of Medicine at USC's Keck School of Medicine.

Dr. Dubé earned his medical degree from Boston University School of Medicine. He then went on to complete his internship, residency and fellowship at LAC+USC Medical Center, specializing in Infectious Diseases.

Recent HIV Risk Behavior and Partnership Type Predict HIV Pre-Exposure Prophylaxis Adherence in Men Who Have Sex with Men AIDS Patient Care STDS. 2019 May; 33(5):220-226. . View in PubMed

Randomized Trial of a Health Coaching Intervention to Enhance Retention in Care: California Collaborative Treatment Group 594 AIDS Behav. 2018 Aug; 22(8):2698-2710. . View in PubMed

Effect of rectal douching/enema on rectal gonorrhoea and chlamydia among a cohort of men who have sex with men on HIV pre-exposure prophylaxis Sex Transm Infect. 2018 11; 94(7):508-514. . View in PubMed

Brief Report: Changes in Plasma RANKL-Osteoprotegerin in a Prospective, Randomized Clinical Trial of Initial Antiviral Therapy: A5260s J Acquir Immune Defic Syndr. 2018 07 01; 78(3):362-366. . View in PubMed

Trajectories and Predictors of Longitudinal Preexposure Prophylaxis Adherence Among Men Who Have Sex With Men J Infect Dis. 2018 10 05; 218(10):1551-1559. . View in PubMed

Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection Clin Infect Dis. 2017 May 15; 64(10):1422-1429. . View in PubMed

Changes in plasma levels of oxidized lipoproteins and lipoprotein subfractions with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy and associations with common carotid artery intima-media thickness: ACTG 5260s Antivir Ther. 2017; 22(2):113-126. . View in PubMed

Tenofovir Disoproxil Fumarate-Associated Fanconi Syndrome in an Human Immunodeficiency Virus (HIV)-Uninfected Man Receiving HIV Pre-Exposure Prophylaxis Open Forum Infect Dis. 2017; 4(3):ofx149. . View in PubMed

Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s Open Forum Infect Dis. 2016 Sep; 3(3):ofw174. . View in PubMed

Genital Epstein Barr Virus is associated with higher prevalence and persistence of anal human papillomavirus in HIV-infected men on antiretroviral therapy BMC Infect Dis. 2016 Jan 25; 16:24. . View in PubMed

Nucleoside-Sparing Regimens With Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue J Acquir Immune Defic Syndr. 2016 06 01; 72(2):e48-50. . View in PubMed

Distinct cytokine/chemokine network in semen and blood characterize different stages of HIV infection AIDS. 2016 Jan; 30(2):193-201. . View in PubMed

Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection AIDS. 2016 11 13; 30(17):2625-2633. . View in PubMed

Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260s J Infect Dis. 2016 09 01; 214(5):748-52. . View in PubMed

Brief Report: Effect of CMV and HIV Transcription on CD57 and PD-1 T-Cell Expression During Suppressive ART J Acquir Immune Defic Syndr. 2016 06 01; 72(2):133-7. . View in PubMed

A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness AIDS. 2015 Sep 10; 29(14):1775-83. . View in PubMed

Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy Sci Rep. 2015 Aug 24; 5:13179. . View in PubMed

Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s Clin Infect Dis. 2015 Aug 15; 61(4):651-60. . View in PubMed

Genital Cytomegalovirus Replication Predicts Syphilis Acquisition among HIV-1 Infected Men Who Have Sex with Men PLoS One. 2015; 10(6):e0130410. . View in PubMed

Factors associated with high transmission risk and detectable plasma HIV RNA in HIV-infected MSM on ART Int J STD AIDS. 2014 Sep; 25(10):734-41. . View in PubMed

Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment J Virol. 2014 Jul; 88(14):7818-27. . View in PubMed

Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent Pharmacogenomics J. 2014 Apr; 14(2):160-70. . View in PubMed

Virologic correlates of anti-CMV IgG levels in HIV-1-infected men J Infect Dis. 2014 Feb 01; 209(3):452-6. . View in PubMed

Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation Clin Infect Dis. 2013 Nov; 57(10):1483-8. . View in PubMed

Mitochondrial DNA variation and changes in adiponectin and endothelial function in HIV-infected adults after antiretroviral therapy initiation AIDS Res Hum Retroviruses. 2013 Oct; 29(10):1293-9. . View in PubMed

Shedding of HIV and human herpesviruses in the semen of effectively treated HIV-1-infected men who have sex with men Clin Infect Dis. 2013 Aug; 57(3):441-7. . View in PubMed

Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy AIDS. 2010 Mar 27; 24(6):885-90. . View in PubMed

Genetic analysis implicates resistin in HIV lipodystrophy AIDS. 2008 Aug 20; 22(13):1561-8. . View in PubMed

Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy Clin Infect Dis. 2006 Sep 01; 43(5):645-53. . View in PubMed

Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy PLoS Med. 2006 Mar; 3(3):e52. . View in PubMed

C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s AIDS. 2004 Dec 03; 18(18):2434-7. . View in PubMed

Probiotics, soluble fiber, and L-Glutamine (GLN) reduce nelfinavir (NFV)- or lopinavir/ritonavir (LPV/r)-related diarrhea J Int Assoc Physicians AIDS Care (Chic). 2004 Oct-Dec; 3(4):121-9. . View in PubMed

Lipid abnormalities Clin Infect Dis. 2003 Apr 01; 36(Suppl 2):S79-83. . View in PubMed

A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study Team J Infect Dis. 2003 Apr 01; 187(7):1046-52. . View in PubMed

Metabolic effects of nandrolone decanoate and resistance training in men with HIV Am J Physiol Endocrinol Metab. 2002 Dec; 283(6):E1214-22. . View in PubMed

Elevated blood pressure in subjects with lipodystrophy AIDS. 2001 Oct 19; 15(15):2001-10. . View in PubMed

Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus J Clin Endocrinol Metab. 1999 Apr; 84(4):1268-76. . View in PubMed

Metabolic complications of antiretroviral therapies AIDS Clin Care. 1998 Jun; 10(6):41-4. . View in PubMed

Evaluation of pulsed-field gel electrophoresis as a typing system for Candida rugosa: comparison of karyotype and restriction fragment length polymorphisms J Clin Microbiol. 1996 Jun; 34(6):1494-6. . View in PubMed

Clarithromycin therapy for bacteremic Mycobacterium avium complex diseaseA randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team. Ann Intern Med. 1994 Dec 15; 121(12):905-11. . View in PubMed

Effects of hyperthyroidism and hypothyroidism on human red blood cell Ca2+-ATPase activity J Clin Endocrinol Metab. 1986 Feb; 62(2):253-7. . View in PubMed

Powered by SC CTSI
Go to Top